Autism Starts Months before Symptoms Appear. Flagging Children Early Offers The Possibility Of More Effective Treatment
Articles by Medical News
- FDA Expands Approval of SPIRIVA® RESPIMAT®, Steroid-free Respimat now approved as asthma treatment for age 6 and older
- Supplemental New Drug Application (sNDA) approved under priority review from the FDA
- FDA also granted pediatric exclusivity to SPIRIVA
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA RESPIMAT for the long-term, once-daily maintenance treatment of asthma in people age 6 and older. SPIRIVA RESPIMAT is not a treatment for sudden asthma symptoms.
New Hiv Infections Drop 18 Percent In Six Years. Decline signals HIV prevention and treatment efforts in the U.S. are paying off, but not all communities are seeing the same progress.
The U.S. FDA Approves New Psoriasis Drug Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.
Edited embryos should be allowed in specific contexts, National Academies say
COMPOUND OFFERS A POTENTIAL TREATMENT FOR FIGHTING DRUG-RESISTANT MALARIA PARASITES.
Microfluidics, electronics and inkjet technology underlie a newly developed all-in-one biochip from Stanford that can analyze cells for research and clinical applications.
If the start of 2017 is any indication, the microbiome field which aims to turn human gut bacteria and other body microorganisms into therapies is thriving on various levels.
Harvard scientists are testing a neural prosthesis that uses arrays of microscopic coils to generate magnetic fields that can target specific regions of the brain, such as the visual cortex to simulate sight. After a proof-of-concept study in mice, the researchers intend to evaluate the technology in primates and rats, and say the implant potentially could be used for nerve stimulation in other areas of the body.
A California dietary supplement distributor has been ordered by a federal court to stop selling its products, which were found to contain unsafe ingredients including 1, 3-dimethylamylamine (DMAA).